NHCCC Focuses on Enhancing the Cancer Survivorship Experience at Upcoming Meeting

The New Hampshire Comprehensive Cancer Collaboration (NH CCC) will host its 12th annual meeting, Partnerships in Healthcare : Enhancing the Cancer Survivorship Experience, on April 5 in Concord.  Attended by more than 175 in 2016, this year’s participants will learn how community partnerships and collaborative efforts can improve outcomes and enhance the cancer survivorship experience.

The meeting’s first plenary speaker, Edward Benz Jr., MD, will be addressing the importance of community partnerships toward advancing cancer care and research. Dr. Benz is president and CEO emeritus of Dana-Farber Cancer Institute. He will also speak to the now recognized concept of cancer being a chronic disease that results in more survivors, whose needs must be met within their communities.

The NHCCC Annual Meeting also features plenary speaker, Mandi Pratt-Chapman, who will address the challenges providers are facing nationally with implementing Survivorship Care Plans in practice. Ms. Pratt-Chapman is the Associate Center Director for Patient-Centered Initiatives and Health Equity at the GW Cancer Center in Washington DC. She will be presenting a report from a national survey of providers regarding implementation of survivorship care plans.

“We are thrilled to have such high caliber speakers willing to share their extensive knowledge and expertise with people from across the state with the same goal of improving the survivorship experience for those who are living with cancer,” said Robert Gerlach, Associate Director for Administration & Scientific Affairs at Dartmouth-Hitchcock Norris Cotton Cancer Center and Chair of the NHCCC’s Board of Directors.

Breakout sessions will provide practical, evidence-based, policy and system change strategies and solutions for implementing survivorship care plans. Providers from around the state are presenting their perspectives on offering the best quality of care for cancer survivors in four unique sessions. An additional session will address the emerging issue of arsenic in private well water in NH and the related cancer risk. 

The meeting will wrap-up with a closing plenary from Hester Hill Schnipper, LICSW, BCD, OSW-C who will discuss living well after cancer with a focus on patient and family needs. She is the author of two books that help women navigate a breast cancer diagnosis, and offer a guide to life after treatment. Ms. Hill Schnipper is chief of oncology social work at Beth Israel Deaconess Medical Center and adjunct professor at Simmons College and Boston University Schools of Social Work.

The NHCCC Annual Meeting is held for those individuals, organizational leaders, and decision makers who are interested in addressing policy and systems change to improve care planning for all cancer survivors in New Hampshire communities. Additionally, the conference is targeting patients, providers, nurses, social workers, cancer registrars, health educators, and others involved in oncology care coordination.

Pre-registration for the meeting closes Tuesday, March 28th, but due to the state of demand for this conference, attendees will be able to register on the day of the meeting for $85.00. Continuing education credits will be offered. Please visit www.NHCancerPlan.org for additional information and to download a flyer with a full description of the agenda and breakout presentations.

 

NH CCC 12th Annual Meeting

Date: Wednesday, April 5, 2017

Location: Courtyard by Marriott, Grappone Conference Center, Concord, NH

For more information: www.NHCancerPlan.org

 

About New Hampshire Comprehensive Cancer Collaboration

The New Hampshire Comprehensive Cancer Collaboration (NH CCC) is a dedicated partnership of individuals and organizations committed to eliminating cancer – the leading cause of death in New Hampshire. The NH CCC developed the New Hampshire Comprehensive Cancer Control Plan to address the following priorities:

  • Foster communities and systems that support and reinforce healthy lifestyles
  • Prevent and detect cancer at its earliest stage
  • Optimize quality of life for those affected by cancer
  • Report on emerging issues in cancer